Financial Statements — MDWD
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 1.06 | 3.79 | 7.73 | 16.99 |
| Inventory | 3.84 | 3.21 | 1.99 | 1.40 |
| Total Current Assets | 43.08 | 37.31 | 16.81 | 21.52 |
| Total Non-current Assets | 23.92 | 19.98 | 4.30 | 4.68 |
| Total Assets | 67.00 | 57.30 | 21.11 | 26.20 |
| Total Current Liabilities | 29.07 | 22.61 | 10.42 | 9.66 |
| Total Non-current Liabilities | 17.81 | 16.82 | 12.93 | 14.43 |
| Total Liabilities* | 46.88 | 39.43 | 23.34 | 24.09 |
| Retained Earnings | (219.09) | (190.86) | (156.45) | (141.00) |
| Total Stockholder Equity | 20.12 | 17.87 | (2.23) | 2.12 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 5.71 | 5.06 | 4.67 | 6.06 |
| Cost of Revenue* | 4.37 | 4.62 | 3.56 | 3.70 |
| Gross Profit | 1.34 | 0.45 | 1.11 | 2.36 |
| Research & Development | 3.49 | 1.90 | 2.19 | 2.66 |
| Selling, General & Admin | 2.11 | 1.81 | 1.35 | 1.75 |
| Total Operating Expenses | 7.06 | 4.93 | 4.79 | 5.26 |
| Operating Income | (5.72) | (4.48) | (3.67) | (2.89) |
| Pretax Income | (13.28) | (6.31) | (4.35) | (3.18) |
| Tax Provision | 0.04 | -0.00 | 0.00 | 0.02 |
| Net Income | (13.32) | (6.30) | (4.35) | (3.19) |
| Basic EPS | (1.23) | (0.68) | -- | -- |
| Diluted EPS | (1.23) | (0.68) | (0.13) | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (5.76) | (3.62) | (5.25) | (0.98) |
| Financing Cash Flow | 0.55 | (0.10) | (0.73) | (0.17) |
